COVAX: COVID-19 vaccine planned for global rollout starting Q1 2021 – WHO (18 December 2020)

United Nations published this video item, entitled “COVAX: COVID-19 vaccine planned for global rollout starting Q1 2021 – WHO (18 December 2020)” – below is their description.

As governments move to secure COVID-19 vaccines for their populations, choosing these treatments should not be viewed as “some kind of nationalistic footrace”, with some countries winning and others losing, a senior official with the World Health Organization (WHO) told journalists

————————

COVAX, the global initiative to ensure rapid and equitable access to COVID-19 vaccines for all countries, regardless of income level, today announced that it had arrangements in place to access nearly two billion doses of COVID-19 vaccine candidates, on behalf of 190 participating economies. For the vast majority of these deals, COVAX has guaranteed access to a portion of the first wave of production, followed by volume scales as further supply becomes available. The arrangements announced today will enable all participating economies to have access to doses in the first half of 2021, with first deliveries anticipated to begin in the first quarter of 2021 – contingent upon regulatory approvals and countries’ readiness for delivery.

Given these are arrangements for 2 billion doses of vaccine candidates which are still under development, COVAX will continue developing its portfolio: this will be critical to achieve its goal of securing access to 2 billion doses of safe and effective, approved vaccines that are suitable for all participants’ contexts, and available by the end of 2021. However, today’s announcements offer the clearest pathway yet to end the acute phase of the pandemic by protecting the most vulnerable populations around the world. This includes delivering at least 1.3 billion donor-funded doses of approved vaccines in 2021 to the 92 low- and middle-income economies eligible for the COVAX AMC.

The new deals announced today include the signing of an advance purchase agreement with AstraZeneca for 170 million doses of the AstraZeneca/Oxford candidate, and a memorandum of understanding (MoU) with Johnson & Johnson for 500 million doses of the Janssen candidate, which is currently being investigated as a single dose vaccine.. These deals are in addition to existing agreements COVAX has with the Serum Institute of India (SII) for 200 million doses – with options for up to 900 million doses more – of either the AstraZeneca/Oxford or Novavax candidates, as well as a statement of intent for 200 million doses of the Sanofi/GSK vaccine candidate.

In addition to this, COVAX also has – through R&D partnership agreements – first right of refusal in 2021 to access potentially more than one billion doses (based on current estimates from the manufacturing processes under development) that will be produced, subject to technical success and regulatory approval, by candidates in the COVAX R&D Portfolio.

United Nations YouTube Channel

Got a comment? Leave your thoughts in the comments section, below. Please note comments are moderated before publication.


About This Source - United Nations

The United Nations (UN) was established after World War II with the aim of preventing future wars. The organization is financed by assessed and voluntary contributions from its member states.

The UN’s chief administrative officer is the Secretary-General, currently Portuguese politician and diplomat António Guterres, who began his five year-term on 1 January 2017.

 

Recent from United Nations:

Uganda, gaza, lebanon & other topics - daily press briefing (19 january 2024) 1

Uganda, Gaza, Lebanon & other topics – Daily Press Briefing (19 January 2024)

Very First Int’l Day of Clean Energy (26 Jan) | United Nations Secretary-General

UN News in Brief (19 January 2024) | United Nations

In This Story: AstraZeneca

AstraZeneca plc/AB (LON: AZN) is a British-Swedish multinational pharmaceutical and biopharmaceutical company with its headquarters in Cambridge, United Kingdom and Södertälje, Sweden. Its R&D is concentrated in Cambridge in United Kingdom, Södertälje in Sweden, and Maryland and Toronto in North America.

3 Recent Items: AstraZeneca

Disease X: The next possible global health threat?

CHAOS In Ecuador As Armed Gangsters STORM TV Station! State Of Emergency! – Stay Free #281 PREVIEW

GSK, Amneal, Kaléo delist patents from FDA’s orange book

In This Story: COVID-19

Covid-19 is the official WHO name given to the novel coronavirus which broke out in late 2019 and began to spread in the early months of 2020.

Symptoms of coronavirus

The main symptoms of coronavirus are:

  • a persistent new cough (non productive, dry)
  • a high temperature (e.g. head feels warm to the touch)
  • shortness of breath (if this is abnormal for the individual, or increased)

Latest News about Covid-19

Below are stories from around the globe related to the 2020 outbreak of novel Coronavirus – since the WHO gave the Covid-19 naming. Most recent items are posted nearest the top.

5 Recent Items: COVID-19

Global National: Jan. 19, 2024 | Health data shows influenza, COVID-19 cases decreasing in Canada

Stock market today: Dow, S&P 500 hit record highs as tech stocks soar | January 19, 2024

Stock market today: Stocks climb with techs ready to roar | January 19, 2023

Dr Anthony Fauci ‘became part of the problem’ when it came to the spread of Covid misinformation

WEF summit: Canada warns of future supply shocks amid global instability

In This Story: India

India, officially the Republic of India, is a country in South Asia. It is the second-most populous country, the seventh-largest country by land area, and the most populous democracy in the world. New Delhi is the capital.

It has an exceptionally diverse population, with Hindus, Muslims, Christians, Sikhs, Buddhists, Jains and other religions speaking over 21 recognised languages.

2 Recent Items: India

Why The World Is Rushing Back To The Moon

A prolonged dry spell across the Indian-administered Kashmir

In This Story: Novavax

Novavax, Inc. (NASDAQ: NVAX) is an American vaccine development company headquartered in Gaithersburg, Maryland, with additional facilities in Rockville, Maryland and Uppsala, Sweden.

2 Recent Items: Novavax

Lightning Round: Coinbase is too expensive ‘let it come in’, says Jim Cramer

Lightning Round: The tech rally will reinvigorate Arm, says Jim Cramer

In This Story: Sanofi

Sanofi S.A. is a French multinational pharmaceutical company headquartered in Paris, France, as of 2013 the world’s fifth-largest by prescription sales.

2 Recent Items: Sanofi

Sanofi CEO Paul Hudson: We’ve got perhaps the world’s best immunology pipeline

FTC vs Big Pharma: Sanofi drops Maze deal

In This Story: Vaccine

A vaccine is a biological preparation that provides active acquired immunity to a particular infectious disease. A vaccine typically contains an agent that resembles a disease-causing microorganism and is often made from weakened or killed forms of the microbe, its toxins, or one of its surface proteins.

9 Recent Items: Vaccine

‘National incident’ declared over measles outbreak

Southern Africa cholera outbreak: Zambia and Zimbabwe lead vaccine drives

People born 1998-2004 ‘should get measles vaccine’ #measles #vaccine

N.Y. midwife falsified thousands of vaccine records

Vaccines: There’s ‘so much noise’ around facts: Moderna CEO

Vaccine for RSV approved in Australia | 9 News Australia

IT’S OVER! This Fauci SCANDAL Is Just The Tip Of The Iceberg

‘Lunatics have taken over!’ | Neil Oliver on air strikes in Yemen, Britain’s borders and more

They KNEW This Vaccine Data Was TRUE But CENSORED It Anyway!!

In This Story: World Health Organization

The World Health Organization is a specialized agency of the United Nations responsible for international public health. The WHO Constitution, which establishes the agency’s governing structure and principles, states its main objective as “the attainment by all peoples of the highest possible level of health.”

3 Recent Items: World Health Organization

WHO’s Science in 5: Sun and skin cancer #shorts

WHO’s Science in 5: Sun and skin cancer

WHO Describes ‘Atrocious’ Living Conditions in Gaza

Leave a Comment

We don't require your email address, or your name, for anyone to leave a comment. If you do add an email address, you may be notified if there are replies to your comment - we won't use it for any other purpose. Please make respectful comments, which add value, and avoid personal attacks on others. Links are not allowed in comments - 99% of spam comments, attempt to post links. Please describe where people may find additional information - for example "visit the UN website" or "search Google for..." rather than posting a link. Comments failing to adhere to these guidelines will not be published.